Viral and Non-viral Vectors in Gene Therapy: Technology Development and Clinical Trials (Q35551705)

8 August 2017

1 reference

title

Viral and non-viral vectors in gene therapy: technology development and clinical trials (English)

1 reference

8 August 2017

Viral and Non-viral Vectors in Gene Therapy: Technology Development and Clinical Trials (English)

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529313

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

Kenneth Lundstrom

1 reference

8 August 2017

Teni Boulikas

series ordinal

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14529313

18 March 2024

publication date

1 October 2003

1 reference

Technology in Cancer Research and Treatment

8 August 2017

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

471-486

1 reference

Targeting HER2: recent developments and future directions for breast cancer patients

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Cancer therapy utilizing an adenoviral vector expressing only E1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Enhancing immune responses using suicidal DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

DNA and RNA-based vaccines: principles, progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Alphavirus vectors for vaccine production and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Adeno-associated virus expression systems for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Gene delivery to the eye using adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Heat-directed suicide gene therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Oncolytic adenoviruses for treatment of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Selectively replicating adenoviruses for oncolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

HSV1716 persistence in primary human glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Replicative retroviral vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Gene transduction efficiency in cells of different species by HIV and EIAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Novel cGMP liposomal vectors mediate efficient gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Lipoplexes with alkylphospholipid as new helper lipid for efficient in vitro and in vivo gene transfer in tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Surface characterization of oil-containing polyterephthalamide microcapsules prepared by interfacial polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Endovascular microcoil gene delivery using immobilized anti-adenovirus antibody for vector tethering

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Cytotoxicity of combinations of IFN-beta and chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Recombinant human interleukin-3 administered concomitantly with chemotherapy in patients with relapsed small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Radiation enhances the anti-tumor effects of vaccinia-p53 gene therapy in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200513

Gene therapy & molecular biology

21 January 2018

Boulikas T.

1998

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

The p53 tumor suppressor gene: structure, function and mechanism of action

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

6089

Bernt K. M.

2002

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Gene therapy & molecular biology

18 March 2024

Lundstrom K.

1999

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

7861

Velders M. P.

2001

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

Pharmacological Reviews

493

Hu W.-S.

2000

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

6099

Indraccolo S.

2002

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

4955

Drexler I.

1999

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Gene therapy & molecular biology

18 March 2024

173

Martin F.

1998

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Large unilamellar liposomes with low uptake into the reticuloendothelial system

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

A new procedure for the synthesis of polyethylene glycol-protein adducts; Effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and α2-macroglobulin

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153303460300200513

18 March 2024

Identifiers

1 reference

8 August 2017

1 reference